HomeWatch CareGivers vs ACASA Senior Care

HomeWatch CareGivers wins on TAM and timing, and that’s the axis that matters most right now. With 260 franchised units against ACASA’s 7, the addressable universe is 37x larger—software sales is a numbers game, and even a modest attach rate here produces more booked revenue than fully penetrating ACASA. The FDD is current (fiscal 2026), which removes administrative drag and signals an actively managed, vendor-ready system; ACASA’s DUE filing introduces uncertainty and potential delays that stall pipeline velocity. Procurement terrain tilts further in HomeWatch’s favor: ACASA’s approved-supplier model erects a gatekeeper bottleneck, while nothing in HomeWatch’s profile flags a similar restriction, so you can sell straight to operators without corporate pre-clearance.

ACASA’s eye-popping $6.9M AUV and 40% unit growth scream budget depth, but that budget is trapped inside a micro-TAM with only 7 franchised buyers. The high AUV likely funds caregiver payroll, not back-office technology, so per-unit software spend won’t scale linearly with revenue. Meanwhile, HomeWatch’s $1.36M AUV may seem leaner, yet the aggregate wallet across 260 locations comfortably outpaces ACASA’s total potential. The tradeoff is fewer whales versus a school of solid mid-market accounts—given sales efficiency, the latter closes faster and compounds monthly recurring revenue with traditional territory coverage.

Verdict: HomeWatch CareGivers is the stronger immediate opportunity because its TAM, current filing, and open terrain outweigh ACASA’s per-unit budget advantage.